PMS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.153700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.975200E-01
Normal-vs-Stage2
2.597900E-02
Normal-vs-Stage3
9.447900E-02
Normal-vs-Stage4
2.151400E-01
Stage1-vs-Stage2
1.498560E-01
Stage1-vs-Stage3
7.414000E-02
Stage1-vs-Stage4
3.652400E-01
Stage2-vs-Stage3
7.343900E-02
Stage2-vs-Stage4
9.758400E-01
Stage3-vs-Stage4
1.642010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.737900E-02
Normal-vs-AfricanAmerican
1.696600E-01
Normal-vs-Asian
7.821800E-02
Caucasian-vs-AfricanAmerican
8.051000E-01
Caucasian-vs-Asian
8.089800E-01
AfricanAmerican-vs-Asian
9.496800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.394800E-01
Normal-vs-Female
6.616100E-02
Male-vs-Female
3.868400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.697800E-01
Normal-vs-Age(41-60Yrs)
4.595000E-01
Normal-vs-Age(61-80Yrs)
1.703750E-02
Normal-vs-Age(81-100Yrs)
3.670600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.063600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.553600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.081800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.115000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.292800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.838000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.678290E-02
Normal-vs-Daily Drinker
9.424300E-02
Normal-vs-Weekly Drinker
6.346300E-02
Normal-vs-Occasional Drinker
1.576820E-01
Normal-vs-Social Drinker
2.776800E-01
Non Drinker-vs-Daily Drinker
5.230200E-01
Non Drinker-vs-Weekly Drinker
3.923600E-01
Non Drinker-vs-Occasional Drinker
5.695800E-02
Non Drinker-vs-Social Drinker
1.721740E-02
Daily Drinker-vs-Weekly Drinker
8.693200E-01
Daily Drinker-vs-Occasional Drinker
3.095600E-01
Daily Drinker-vs-Social Drinker
1.471010E-01
Weekly Drinker-vs-Occasional Drinker
3.628000E-01
Weekly Drinker-vs-Social Drinker
1.575190E-01
Occasional Drinker-vs-Social Drinker
5.708200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.641000E-01
Normal-vs-Grade 2
7.861600E-01
Normal-vs-Grade 3
7.170000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.941230E-01
Grade 1-vs-Grade 3
6.834600E-01
Grade 1-vs-Grade 4
3.641000E-01
Grade 2-vs-Grade 3
8.997700E-02
Grade 2-vs-Grade 4
7.861600E-01
Grade 3-vs-Grade 4
7.170000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.386460E-02
Normal-vs-NonDiabetic
5.648000E-02
Diabetic-vs-NonDiabetic
6.053500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.897450E-01
Normal-vs-NoPancreatitis
2.241700E-02
Pancreatitis-vs-NoPancreatitis
4.562000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.707400E-01
Normal-vs-N1
3.172400E-02
N0-vs-N1
6.497200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.012000E-01
Normal-vs-TP53-NonMutant
2.247000E-01
TP53-Mutant-vs-TP53-NonMutant
3.369200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
